Skip to content

Telesair

7 viewers · 30d

Total raised

$3.0M

+$3.0M this year

1 filing since 2026 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $3.0M
ROUNDS
1
INVESTORS
12
FOUNDED
N/A
HQ
Irvine, CA
SECTOR
Other Technology
EMPLOYEES
N/A
30D VIEWERS
7

AI overview

Updated

Telesair is a medical technology startup founded in 2020 that develops compact and mobile respiratory care solutions. The company's primary focus is on enabling earlier patient discharge from hospitals to home settings, aiming to improve outcomes for individuals with respiratory insufficiency.

What sets it apart

The company stands out by designing and manufacturing its cost-effective and user-friendly High Flow Oxygen Therapy (HFOT) system in the United States, led by veterans from the respiratory industry. Telesair achieved rapid regulatory success, obtaining both an MDR CE Mark and FDA clearance for its primary product in less than one year.

Funding history

1 round
EquityFeb 4, 2026
Form D
+$3.0M$3.0M total

Latest SEC filings

via EDGAR · CIK 0001964253
Form D · Feb 4, 2026View on EDGAR

Products

1 tracked

Bonhawa High Flow Oxygen Therapy (HFOT) system

Oxygen Therapy System

The Bonhawa is a standalone, lightweight, and mobile device designed to treat respiratory insufficiency. It delivers high flows of oxygen up to 80 L/min and is designed to support patient mobility and smooth a patient's transition from the hospital to a homecare setting.

  • Compact and mobile design for increased patient mobility
  • Instantly ready for use upon power-up
  • Touch screen that is visible from a hallway
  • Upgradeable monitoring capabilities

Links

WebsiteSEC EDGAR filings